About Enterra Medical
Feel the Enterra® Therapy difference
If you’re living with gastroparesis, you know that it can cause pain and discomfort that goes beyond malnutrition or missed meals. It can make you feel like you’re missing out on everything else.
That’s why Enterra Medical was founded: to help people with gastroparesis find the relief to take back their seat at the table.
You’re not alone
Enterra Therapy was originally developed by Medtronic and indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis. In 2022, Enterra Medical was formed to focus exclusively on helping more people find relief through Enterra Therapy. Medtronic continues to be an important partner and will continue to handle customer and patient support.
Unlike diet modifications or surgery, the Enterra System is the first and only device indicated to relieve chronic nausea and vomiting symptoms. A small, implantable device that’s customizable and reversible, the Enterra System gently stimulates your stomach, which will help reduce the nausea and vomiting associated with gastroparesis. And over 15,000 people have already received Enterra Therapy.
The journey to relief may not be simple for everyone, but Enterra Medical is here to help you navigate diagnosis, consider the treatment options that are right for you, and find the relief you’ve been searching for.
The information provided on this site is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always talk to your doctor about the best treatment options for your individual situation.
MKT-D-00605, Rev A
IMPORTANT SAFETY INFORMATION
The Enterra® Therapy System for gastric electrical stimulation (GES) is indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis. This system has not been evaluated for pregnant women, for use in patients under the age of 18, or patients over the age of 70. Patients should always discuss potential risks and benefits with their clinician.